From what's tradeable today to what's realistically coming. Bigger = more selling pressure ahead.
Risk is driven by relentless recent issuance rather than toxic converts. Series C preferred (453,026 shares, fixed 1:1, modest ~4.6% of float) and all warrants priced $1.50-$40 are OUT of the money vs the $1.03 stock, so instantaneous conversion/exercise pressure is limited. But the company sells continuously: quarterly ATM, two June 2026 registered directs priced as low as $0.70, plus serial Feb/Dec 2025 warrant inducements with Armistice that REPRICED warrants from $6.82 to $2.90 — establishing a clear precedent that nominally OTM warrants get repriced into exercisable money. Share count tripled post-reverse-split. Score reflects very high recent-activity and historical-pattern components against a currently OTM/low-convertible structure.
Share Structure
Float to Fully Diluted Breakdown
Reported float from Insight Sentry. Adjusted based on SEC filing analysis.
Float Discrepancy: our SEC analysis shows 9.81M vs 12.43M reported — overstated 27%
Insight Sentry float 9,813,542 sits below outstanding 14,712,528 (sane). Our looser reconstruction (~11.2M) is higher because we only subtract Rossi/directors and Armistice's capped common; the feed applies a tighter restricted-share haircut. The events most likely missing from any standard feed are the two June 18, 2026 registered-direct issuances (884K shares) and continued ATM dribble — all imm...
Reported float + filing adjustments
MEDIUM confidence
Registered and convertible shares that could enter the float relative to current float size.
Share estimates are approximate. Convertible share counts based on current price. Review SEC filings for exact terms.
See the full breakdown
Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.
Sign in to continue- 1-for-10·Mar 18, 2025~1 yr ago
- 1-for-20·Aug 4, 2021~5 yr ago
- 1-for-6·Mar 29, 2019~7 yr ago
- 1-for-100·May 9, 2003~23 yr ago
- ▸Active ATM with H.C. Wainwright (baby-shelf limited, ~$291K I.B.6 capacity remaining)
- ▸Baby shelf S-3 333-291582 ($30M authorized, I.B.6 capped near exhaustion)
- ▸Serial best-efforts registered directs at deep discounts ($0.70)
- ▸Series C preferred 1:1 conversions feeding common (2.6M+ already converted)
- ▸Warrant inducement/repricing cycle with Armistice Capital
Market Data
$0.51
$9.90M
15.30M
12.43M
19.50M